Although an intriguing potential association of the gut microbiome with Alzheimer's disease
(AD) has attracted recent interest, few studies have directly assessed this relationship or …

Alzheimer's disease (AD) is a neurodegenerative disorder that has affected millions of
people worldwide. However, currently, there is no treatment to cure the disease. The AD …

Background Genome-wide association studies (GWAS) have identified numerous
susceptibility loci for Alzheimer's disease (AD). However, utilizing GWAS and multi-omics …

Abstract P‐Wave Dispersion (PWD) is an ECG parameter defined as the difference between
the longest and the shortest P‐Wave duration. PWD has been associated with hypertension …

Alzheimer's disease (AD) is a complex neurodegenerative disorder with multiple
dysfunctional pathways. Therefore, a sophisticated treatment strategy that simultaneously …

Background Gut microbiota influence the central nervous system through gut-brain-axis.
They also affect the neurological disorders. Gut microbiota differs in patients with …

Increasing life expectancies are unfortunately accompanied by increased prevalence of
Alzheimer's disease (AD). Regrettably, there are no current therapeutic options capable of …

Die Zahl der Patienten mit Alzheimer-Demenz wird in den nächsten Jahren durch den
demografischen Wandel stark zunehmen. Die derzeit verfügbaren Therapien können den …

Artificial intelligence (AI) technologies are used extensively in health science-related fields.
In this book chapter, we will briefly introduce AI applications in clinical data studies focusing …

It is widely recognized that Alzheimer's disease (AD) has a complicate link to renin-
angiotensin system (RAS). It is known that cerebrovascular disease has some connections …